NK/T lymphoma (I/II stage)
Conditions
Interventions
treatment group:LVP(L-asparaginase 6000IU/m2 d1-5+Vincristine 1.4mg/m2 d1,no more than 2mg + prednisoned 45mg d1-5+)repeated every 21 days
radiotherapy
Sponsors
Department of Medical Oncology, Cancer Center, West China Hospital of Sichuan University
Eligibility
Sex/Gender
Male
Age
16 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. NK/T lymphoma(Stage I or stage II) proved by pathology and immunohistology; 2. No chemotherapy or radiation was administered since diagnosis; 3. Performance status as ECOG 0-2 and no contraindication to chemotherapy; 4. Expectation of life was over 12 weeks; 5. Voluntary participation and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Patients combined with any unstable systemic diseases; 3. Hypersensitiveness to any kind of trial regime; 4. Any conditions that the investigator regards to be not suitable for current study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response Rate;Grade 3/4 toxicities;Disease-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to progress;overall survival rate;survival rate at year 1 and year 2; | — |
Countries
China
Contacts
Public ContactLiqun Zou
Outcome results
None listed